Pages that link to "Q46259554"

The following pages link to SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents (Q46259554):

Displaying 18 items.

• Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (Q30612936) (← links)
• Histaminergic system in brain disorders: lessons from the translational approach and future perspectives. (Q34568925) (← links)
• Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. (Q34822642) (← links)
• New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present). (Q38153063) (← links)
• Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities (Q38212433) (← links)
• Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets. (Q38286222) (← links)
• Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review (Q38618630) (← links)
• SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy (Q42656164) (← links)
• The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats (Q42691812) (← links)
• Design, synthesis, biological evaluation, and molecular docking of novel flavones as H3 R inhibitors. (Q48092937) (← links)
• The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents (Q48512439) (← links)
• Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017). (Q50044639) (← links)
• 5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats. (Q50420988) (← links)
• The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats (Q50421768) (← links)
• Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. (Q55180784) (← links)
• Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats (Q64228128) (← links)
• The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents (Q91620137) (← links)
• Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD? (Q96953395) (← links)